BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35350772)

  • 1. Epigenetic alterations at distal enhancers are linked to proliferation in human breast cancer.
    Ankill J; Aure MR; Bjørklund S; Langberg S; ; Kristensen VN; Vitelli V; Tekpli X; Fleischer T
    NAR Cancer; 2022 Mar; 4(1):zcac008. PubMed ID: 35350772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation at enhancers identifies distinct breast cancer lineages.
    Fleischer T; Tekpli X; Mathelier A; Wang S; Nebdal D; Dhakal HP; Sahlberg KK; Schlichting E; ; Børresen-Dale AL; Borgen E; Naume B; Eskeland R; Frigessi A; Tost J; Hurtado A; Kristensen VN
    Nat Commun; 2017 Nov; 8(1):1379. PubMed ID: 29123100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.
    Franco HL; Nagari A; Malladi VS; Li W; Xi Y; Richardson D; Allton KL; Tanaka K; Li J; Murakami S; Keyomarsi K; Bedford MT; Shi X; Li W; Barton MC; Dent SYR; Kraus WL
    Genome Res; 2018 Feb; 28(2):159-170. PubMed ID: 29273624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer.
    Taberlay PC; Statham AL; Kelly TK; Clark SJ; Jones PA
    Genome Res; 2014 Sep; 24(9):1421-32. PubMed ID: 24916973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pterostilbene Changes Epigenetic Marks at Enhancer Regions of Oncogenes in Breast Cancer Cells.
    Harandi-Zadeh S; Boycott C; Beetch M; Yang T; Martin BJE; Ren K; Kwasniak A; Dupuis JH; Lubecka K; Yada RY; Howe LJ; Stefanska B
    Antioxidants (Basel); 2021 Jul; 10(8):. PubMed ID: 34439480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets.
    Olsson AH; Volkov P; Bacos K; Dayeh T; Hall E; Nilsson EA; Ladenvall C; Rönn T; Ling C
    PLoS Genet; 2014 Nov; 10(11):e1004735. PubMed ID: 25375650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.
    Fleischer T; Haugen MH; Ankill J; Silwal-Pandit L; Børresen-Dale AL; Hedenfalk I; Hatschek T; Tost J; Engebraaten O; Kristensen VN
    Mol Oncol; 2024 Apr; ():. PubMed ID: 38671580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer.
    Heilmann K; Toth R; Bossmann C; Klimo K; Plass C; Gerhauser C
    Oncogene; 2017 Nov; 36(46):6446-6461. PubMed ID: 28759043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNMIVD: DNA methylation interactive visualization database.
    Ding W; Chen J; Feng G; Chen G; Wu J; Guo Y; Ni X; Shi T
    Nucleic Acids Res; 2020 Jan; 48(D1):D856-D862. PubMed ID: 31598709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide analysis of aberrant methylation of enhancer DNA in human osteoarthritis.
    Lin X; Li L; Liu X; Tian J; Zheng W; Li J; Wang L
    BMC Med Genomics; 2020 Jan; 13(1):1. PubMed ID: 31900157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stilbenoid-Mediated Epigenetic Activation of Semaphorin 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor.
    Beetch M; Lubecka K; Shen K; Flower K; Harandi-Zadeh S; Suderman M; Flanagan JM; Stefanska B
    Mol Nutr Food Res; 2019 Oct; 63(19):e1801386. PubMed ID: 31327173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer.
    Heyn H; Vidal E; Ferreira HJ; Vizoso M; Sayols S; Gomez A; Moran S; Boque-Sastre R; Guil S; Martinez-Cardus A; Lin CY; Royo R; Sanchez-Mut JV; Martinez R; Gut M; Torrents D; Orozco M; Gut I; Young RA; Esteller M
    Genome Biol; 2016 Jan; 17():11. PubMed ID: 26813288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes.
    Aran D; Sabato S; Hellman A
    Genome Biol; 2013 Mar; 14(3):R21. PubMed ID: 23497655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
    Rodenhiser DI; Andrews J; Kennette W; Sadikovic B; Mendlowitz A; Tuck AB; Chambers AF
    Breast Cancer Res; 2008; 10(4):R62. PubMed ID: 18638373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of epigenetically regulated genes in breast cancer cell lines.
    Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
    BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis.
    Locke WJ; Zotenko E; Stirzaker C; Robinson MD; Hinshelwood RA; Stone A; Reddel RR; Huschtscha LI; Clark SJ
    Clin Epigenetics; 2015; 7(1):52. PubMed ID: 25960784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.